FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Dextrose 5% Injection Bags
Status: Currently in Shortage
»Date first posted: 10/10/2017
»Therapeutic Categories: Gastroenterology; Other; Pediatric

Expand all

Baxter Healthcare (Revised 10/25/2017)

Company Contact Information:
888-229-0001

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Glucose 5% w/v Intravenous Infusion BP, 50 mL, VIAFLO container Product code FE0086G (NDC 0338-9547-50) Limited quantities will be available in the next few weeks. Baxter will provide further updates as more product becomes available. Baxter Healthcare Corporation in conjunction with FDA has initiated temporary importation of Glucose 5% w/v Intravenous Infusion BP in VIAFLO (non-PVC) container into the U.S. market to address drug shortages.

Dear Health Care Letter, Ireland

Other
Glucose 5% w/v Intravenous Infusion BP, 100 mL, VIAFLO container Product code FE0087 (NDC 0338-9551-50) Limited quantities will be available in the next few weeks. Baxter will provide further updates as more product becomes available. Baxter Healthcare Corporation in conjunction with FDA has initiated temporary importation of Glucose 5% w/v Intravenous Infusion BP in VIAFLO (non-PVC) container into the U.S. market to address drug shortages.

Dear Health Care Letter, Ireland

Other
Glucose 5% Intravenous Infusion in VIAFLEX Container, 50 mL, Product code AHB0086A (NDC 0338-9573-60) Limited quantities will be available in the next few weeks. Baxter will provide further updates as more product becomes available. Baxter Healthcare Corporation in conjunction with FDA has initiated temporary importation of Glucose 5% Intravenous Infusion in VIAFLEX (PVC) container into the U.S. market to address drug shortages.

Dear Health Care Letter, Australia

Other
Glucose 5% Intravenous Infusion in VIAFLEX Container, 100 mL, Product code AHB0087 (NDC 0338-9569-48) Limited quantities will be available in the next few weeks. Baxter will provide further updates as more product becomes available. Baxter Healthcare Corporation in conjunction with FDA has initiated temporary importation of Glucose 5% Intravenous Infusion in VIAFLEX (PVC) Container into the U.S. market to address drug shortages.

Dear Health Care Letter, Australia

Other
5% Dextrose Injection, USP, 50 mL, in VIAFLEX Plastic Container: Single Pack (NDC 0338-0017-41) Quad Pack (NDC 0338-0017-11) Multi Pack (NDC: 0338-0017-31) On allocation Other
5% Dextrose Injection, USP, 100 mL, in VIAFLEX Plastic Container: Single Pack (NDC 0338-0017-48) Quad Pack (NDC 0338-0017-18 Multi Pack (NDC: 0338-0017-38) On allocaton Other
5% Dextrose in Water for Injection in VIAFLEX Container, 50 mL, Product code ABB0086U (NDC 0338-9521-11) Limited quantities will be available in the next few weeks. Baxter will provide further updates as more product becomes available. Baxter Healthcare Corporation in conjunction with FDA has initiated temporary importation of 5% Dextrose Injection in Water for Injection in VIAFLEX (PVC) Container into the U.S. market to address drug shortages.

Dear Health Care Letter, Mexico

Other
5% Dextrose in Water for Injection in VIAFLEX Container, 100 mL, Product code ABB0087U (NDC 0338-9527-72) Limited quantities will be available in the next few weeks. Baxter will provide further updates as more product becomes available. Baxter Healthcare Corporation in conjunction with FDA has initiated temporary importation of 5% Dextrose Injection in Water for Injection in VIAFLEX (PVC) Container into the U.S. market to address drug shortages.

Dear Health Care Letter, Mexico

Other
5% Dextrose Injection USP in VIAFLEX Container, 50 mL, Product code JB0081P (NDC 0338-9533-96) Limited quantities will be available in the next few weeks. Baxter will provide further updates as more product becomes available. Baxter Healthcare Corporation in conjunction with FDA has initiated temporary importation of 5% Dextrose Injection USP in VIAFLEX (PVC) Container into the U.S. market to address drug shortages.

Dear Health Care Letter, Canada

Other
5% Dextrose Injection USP in VIAFLEX Container, 100 mL, Product code JB0082P (NDC 0338-9530-96) Limited quantities will be available in the next few weeks. Baxter will provide further updates as more product becomes available. Baxter Healthcare Corporation in conjunction with FDA has initiated temporary importation of 5% Dextrose Injection USP in VIAFLEX (PVC) Container into the U.S. market to address drug shortages.

Dear Health Care Letter, Canada

Other
5% Dextrose Injection, USP, in MINI-BAG Plus container, 50 mL, Product code JB0040 (NDC 0338-9536-96) Limited quantities will be available in the next few weeks. Baxter will provide further updates as more product becomes available. Baxter Healthcare Corporation in conjunction with FDA has initiated temporary importation of 5% Dextrose Injection USP in MINI-BAG Plus container, VIAFLEX (PVC) plastic container into the U.S. market to address drug shortages.

Dear Health Care Letter, Canada

Other
5% Dextrose Injection, USP, in MINI-BAG Plus container, 100 mL, Product code JB0041P (NDC 0338-9539-72) Limited quantities will be available in the next few weeks. Baxter will provide further updates as more product becomes available. Baxter Healthcare Corporation in conjunction with FDA has initiated temporary importation of 5% Dextrose Injection USP in MINI-BAG Plus container, VIAFLEX (PVC) plastic container into the U.S. market to address drug shortages.

Dear Health Care Letter, Canada

Other
5% Dextrose Injection, USP, in MINI-BAG Plus container, 50 mL, Product code 2B0040 (NDC 0338-0551-11) On allocation Other
5% Dextrose Injection, USP, in MINI-BAG Plus container, 100 mL, Product code 2B0041 (NDC 0338-0551-18) On allocation Other

Fresenius Kabi USA, LLC (Revised 11/17/2017)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5% Dextrose Injection, USP, 100mL (NDC 63323-624-61) Limited availability estimated December 2017 Increase in demand
5% Dextrose Injection, USP, 250mL (NDC 63323-624-74) Limited availability estimated December 2017 Increase in demand
5% Dextrose Injection, USP, 500mL (NDC 63323-624-75) Limited availability estimated December 2017 Increase in demand
5% Dextrose Injection, USP, 1000mL (NDC 63323-624-10) Limited availability estimated December 2017 Increase in demand

Hospira, Inc. (Revised 12/01/2017)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5 %; 50 mL ADD-Vantage™ Flexible Container (NDC 0409-7100-66) Limited supply available. Next delivery: Early December 2017; Estimated recovery: June 2018 Demand increase for the drug
5 %; 100 mL ADD-Vantage™ Flexible Container (NDC 0409-7100-67) Limited supply available. Next delivery: Early December 2017; Estimated recovery: June 2018 Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English